Literature DB >> 10216060

Modelling uveal melanoma.

A J Foss1, I A Cree, P J Dolin, J L Hungerford.   

Abstract

BACKGROUND/AIM: There has been no consistent pattern reported on how mortality for uveal melanoma varies with age. This information can be useful to model the complexity of the disease. The authors have examined ocular cancer trends, as an indirect measure for uveal melanoma mortality, to see how rates vary with age and to compare the results with their other studies on predicting metastatic disease.
METHODS: Age specific mortality was examined for England and Wales, the USA, and Canada. A log-log model was fitted to the data. The slopes of the log-log plots were used as measure of disease complexity and compared with the results of previous work on predicting metastatic disease.
RESULTS: The log-log model provided a good fit for the US and Canadian data, but the observed rates deviated for England and Wales among people over the age of 65 years. The log-log model for mortality data suggests that the underlying process depends upon four rate limiting steps, while a similar model for the incidence data suggests between three and four rate limiting steps. Further analysis of previous data on predicting metastatic disease on the basis of tumour size and blood vessel density would indicate a single rate limiting step between developing the primary tumour and developing metastatic disease.
CONCLUSIONS: There is significant underreporting or underdiagnosis of ocular melanoma for England and Wales in those over the age of 65 years. In those under the age of 65, a model is presented for ocular melanoma oncogenesis requiring three rate limiting steps to develop the primary tumour and a fourth rate limiting step to develop metastatic disease. The three steps in the generation of the primary tumour involve two key processes-namely, growth and angiogenesis within the primary tumour. The step from development of the primary to development of metastatic disease is likely to involve a single rate limiting process.

Entities:  

Mesh:

Year:  1999        PMID: 10216060      PMCID: PMC1723024          DOI: 10.1136/bjo.83.5.588

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  40 in total

Review 1.  Angiogenic factors.

Authors:  J Folkman; M Klagsbrun
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

Review 2.  Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review.

Authors:  W A Manschot; R van Strik
Journal:  Int Ophthalmol       Date:  1992-03       Impact factor: 2.031

3.  Matched group study of preenucleation radiotherapy versus enucleation alone for primary malignant melanoma of the choroid and ciliary body.

Authors:  J J Augsburger; K Lauritzen; J W Gamel; J C Lowry; L W Brady
Journal:  Am J Clin Oncol       Date:  1990-10       Impact factor: 2.339

4.  Traumatic enucleation for posterior uveal melanoma.

Authors:  C S Specht; I W McLean; B W Biscoe
Journal:  Am J Ophthalmol       Date:  1990-11-15       Impact factor: 5.258

5.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

6.  Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years.

Authors:  J A Shields; J J Augsburger; L A Donoso; V B Bernardino; M Portenar
Journal:  Am J Ophthalmol       Date:  1985-11-15       Impact factor: 5.258

7.  A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.

Authors:  M Diener-West; B S Hawkins; J A Markowitz; A P Schachat
Journal:  Arch Ophthalmol       Date:  1992-02

8.  Pre-enucleation irradiation of uveal melanoma.

Authors:  D H Char; T L Phillips
Journal:  Br J Ophthalmol       Date:  1985-03       Impact factor: 4.638

Review 9.  [Preoperative irradiation before enucleation in malignant melanoma of the uvea. Review of the literature and initial personal experiences].

Authors:  N Bornfeld; U Huser; W Sauerwein; A Wessing; H Sack
Journal:  Klin Monbl Augenheilkd       Date:  1989-04       Impact factor: 0.700

Review 10.  Clinical prognostic significance of tumour angiogenesis.

Authors:  P S Craft; A L Harris
Journal:  Ann Oncol       Date:  1994-04       Impact factor: 32.976

View more
  1 in total

1.  Post-menopausal bleeding: a rare presentation of metastatic uveal melanoma.

Authors:  Michael A Coutts; Nicola J Borthwick; John L Hungerford; Ian A Cree
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.